JP2006528936A - 多価髄膜炎菌誘導体化多糖−タンパク質複合体およびワクチン - Google Patents

多価髄膜炎菌誘導体化多糖−タンパク質複合体およびワクチン Download PDF

Info

Publication number
JP2006528936A
JP2006528936A JP2006529366A JP2006529366A JP2006528936A JP 2006528936 A JP2006528936 A JP 2006528936A JP 2006529366 A JP2006529366 A JP 2006529366A JP 2006529366 A JP2006529366 A JP 2006529366A JP 2006528936 A JP2006528936 A JP 2006528936A
Authority
JP
Japan
Prior art keywords
polysaccharide
sba
composition
derivatized
serogroup
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006529366A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006528936A5 (enExample
Inventor
ピー ライアル，ロバート
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Vaccines US Inc
Original Assignee
Aventis Pasteur Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur Inc filed Critical Aventis Pasteur Inc
Publication of JP2006528936A publication Critical patent/JP2006528936A/ja
Publication of JP2006528936A5 publication Critical patent/JP2006528936A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
JP2006529366A 2003-05-07 2004-05-07 多価髄膜炎菌誘導体化多糖−タンパク質複合体およびワクチン Pending JP2006528936A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46858103P 2003-05-07 2003-05-07
PCT/US2004/014466 WO2004103400A2 (en) 2003-05-07 2004-05-07 Multivalent meningococcal derivatized polysaccharide-protein conjugates and corresponding vaccines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010268151A Division JP2011042693A (ja) 2003-05-07 2010-12-01 多価髄膜炎菌誘導体化多糖−タンパク質複合体およびワクチン

Publications (2)

Publication Number Publication Date
JP2006528936A true JP2006528936A (ja) 2006-12-28
JP2006528936A5 JP2006528936A5 (enExample) 2007-06-21

Family

ID=33476662

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2006529366A Pending JP2006528936A (ja) 2003-05-07 2004-05-07 多価髄膜炎菌誘導体化多糖−タンパク質複合体およびワクチン
JP2010268151A Pending JP2011042693A (ja) 2003-05-07 2010-12-01 多価髄膜炎菌誘導体化多糖−タンパク質複合体およびワクチン
JP2014138526A Pending JP2014193929A (ja) 2003-05-07 2014-07-04 多価髄膜炎菌誘導体化多糖−タンパク質複合体およびワクチン

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2010268151A Pending JP2011042693A (ja) 2003-05-07 2010-12-01 多価髄膜炎菌誘導体化多糖−タンパク質複合体およびワクチン
JP2014138526A Pending JP2014193929A (ja) 2003-05-07 2014-07-04 多価髄膜炎菌誘導体化多糖−タンパク質複合体およびワクチン

Country Status (8)

Country Link
US (1) US20050002957A1 (enExample)
EP (2) EP2386313A1 (enExample)
JP (3) JP2006528936A (enExample)
CN (2) CN104225587B (enExample)
AU (2) AU2004240558A1 (enExample)
BR (1) BRPI0410341B8 (enExample)
CA (1) CA2524860C (enExample)
WO (1) WO2004103400A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008513541A (ja) * 2004-09-21 2008-05-01 サノフィ パストゥール インコーポレイテッド 多価髄膜炎菌誘導体化多糖−タンパク質複合体およびワクチン
JP2008517876A (ja) * 2004-08-30 2008-05-29 サノフィ パストゥール インコーポレイテッド 髄膜炎菌由来の誘導体化多糖類−タンパク質の多価コンジュゲートおよびワクチン

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
GB0227346D0 (en) 2002-11-22 2002-12-31 Chiron Spa 741
DK1587537T3 (da) 2003-01-30 2012-07-16 Novartis Ag Injicerbare vacciner mod multiple meningococ-serogrupper
GB0406013D0 (en) * 2004-03-17 2004-04-21 Chiron Srl Analysis of saccharide vaccines without interference
GB0500787D0 (en) 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
RU2379052C2 (ru) 2004-04-30 2010-01-20 Чирон С.Р.Л. Вакцинация менингококковыми конъюгатами
HUE045482T2 (hu) * 2005-06-27 2019-12-30 Glaxosmithkline Biologicals Sa Immunogén készítmény
GB0513071D0 (en) * 2005-06-27 2005-08-03 Glaxosmithkline Biolog Sa Immunogenic composition
US7955817B2 (en) 2005-09-02 2011-06-07 Glaxosmithkline Biologicals S.A. Vaccine protection assay
EP2208999B1 (en) * 2005-09-05 2014-08-27 GlaxoSmithKline Biologicals SA Serum bactericidal assay for N. meningitidis specific antisera
KR101838938B1 (ko) * 2006-03-17 2018-03-15 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카 에즈 레프리젠티드 바이 더 세크러테리 오브 더 디파트먼트 오브 헬스 앤드 휴먼 서비시즈 복합 다가 면역원성 콘쥬게이트의 제조 방법
NZ572054A (en) 2006-03-22 2011-12-22 Novartis Ag Regimens for immunisation with meningococcal conjugates
US10828361B2 (en) * 2006-03-22 2020-11-10 Glaxosmithkline Biologicals Sa Regimens for immunisation with meningococcal conjugates
US8414899B2 (en) 2006-04-11 2013-04-09 Yeda Research And Development Co. Ltd. Vaccines comprising multimeric HSP60 peptide carriers
US7491517B2 (en) * 2006-07-19 2009-02-17 Jeeri R Reddy Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135
CN101428144A (zh) * 2008-12-19 2009-05-13 长春长生生物科技股份有限公司 流脑多糖联合疫苗及制备工艺
CN107261129A (zh) * 2010-05-03 2017-10-20 财团法人生物技术开发中心 用作疫苗的多糖与去毒大肠杆菌(e. coli)不耐热肠毒素(lt)的偶联
CN103623401A (zh) * 2012-08-23 2014-03-12 北京科兴中维生物技术有限公司 多价肺炎球菌荚膜多糖-蛋白质共轭组合物及其制备方法
CN102861326A (zh) * 2012-09-19 2013-01-09 天津康希诺生物技术有限公司 流脑多糖-蛋白质缀合疫苗及制备方法
CN104829711B (zh) * 2014-04-08 2018-04-03 北京天成新脉生物技术有限公司 脑膜炎球菌荚膜多糖单克隆抗体及其应用
CN109890413B (zh) 2016-09-02 2024-04-16 赛诺菲巴斯德股份有限公司 脑膜炎奈瑟氏菌疫苗
CN108743936B (zh) * 2018-06-14 2022-03-15 中国科学院过程工程研究所 一种细菌多糖结合疫苗及其制备方法与应用
CA3155669A1 (en) 2019-09-27 2021-04-01 Pfizer Inc. Neisseria meningitidis compositions and methods thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965714A (en) * 1997-10-02 1999-10-12 Connaught Laboratories, Inc. Method for the covalent attachment of polysaccharides to protein molecules
US20030035806A1 (en) * 2001-05-11 2003-02-20 D'ambra Anello J. Novel meningitis conjugate vaccine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356170A (en) 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4619828A (en) 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
WO1990014837A1 (en) 1989-05-25 1990-12-13 Chiron Corporation Adjuvant formulation comprising a submicron oil droplet emulsion
US5153312A (en) 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
US5422427A (en) 1991-09-17 1995-06-06 The United States Of America As Represented By The United States Department Of Health And Human Services Pneumococcal fimbrial protein A
US5445817A (en) 1992-08-21 1995-08-29 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
US6146902A (en) 1998-12-29 2000-11-14 Aventis Pasteur, Inc. Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965714A (en) * 1997-10-02 1999-10-12 Connaught Laboratories, Inc. Method for the covalent attachment of polysaccharides to protein molecules
US20030035806A1 (en) * 2001-05-11 2003-02-20 D'ambra Anello J. Novel meningitis conjugate vaccine

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008517876A (ja) * 2004-08-30 2008-05-29 サノフィ パストゥール インコーポレイテッド 髄膜炎菌由来の誘導体化多糖類−タンパク質の多価コンジュゲートおよびワクチン
JP2008513541A (ja) * 2004-09-21 2008-05-01 サノフィ パストゥール インコーポレイテッド 多価髄膜炎菌誘導体化多糖−タンパク質複合体およびワクチン

Also Published As

Publication number Publication date
AU2004240558A1 (en) 2004-12-02
BRPI0410341B8 (pt) 2021-05-25
BRPI0410341B1 (pt) 2019-07-16
CN1852733A (zh) 2006-10-25
EP2386313A1 (en) 2011-11-16
CN104225587A (zh) 2014-12-24
WO2004103400A3 (en) 2005-03-24
CN104225587B (zh) 2017-07-21
EP1624888A2 (en) 2006-02-15
HK1204574A1 (en) 2015-11-27
JP2011042693A (ja) 2011-03-03
BRPI0410341A (pt) 2006-05-30
EP1624888B1 (en) 2016-10-12
WO2004103400A2 (en) 2004-12-02
CA2524860C (en) 2016-09-13
CA2524860A1 (en) 2004-12-02
JP2014193929A (ja) 2014-10-09
AU2010257242A1 (en) 2011-01-13
US20050002957A1 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
JP2011068676A (ja) 髄膜炎菌ワクチン接種に対する免疫原性の増強の方法
JP2014193929A (ja) 多価髄膜炎菌誘導体化多糖−タンパク質複合体およびワクチン
JP2012140457A (ja) 多価髄膜炎菌誘導体化多糖−タンパク質複合体およびワクチン
JP2012140456A (ja) 髄膜炎菌由来の誘導体化多糖類−タンパク質の多価コンジュゲートおよびワクチン
US20110070259A1 (en) Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
WO2007102797A2 (en) Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
AU2014213504B2 (en) Multivalent meningococcal derivatized polysaccharide-protein conjugates and corresponding vaccines
AU2011253915A1 (en) Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
MX2007002430A (en) Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
AU2011253978A1 (en) Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070507

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070507

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100601

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100901

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100908

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101001

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101015

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101101

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101109

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110208